Assessment of two-phase dissolution system as a guide in drug formulation: The furosemide case
Furosemide biphasic dissolution test
DOI:
https://doi.org/10.31351/vol33iss1pp137-145Keywords:
Dissolution, biphasic, difference factor, monophasic, similarity factorAbstract
The performance and the quality control of a drug may be evaluated using different approaches. Dissolution test is a corner stone in these processes. However, many issues appeared when using monophasic dissolution system like keeping the sink condition and/or described the in-vivo performance for Class II and IV drugs. Therefore, this study was to evaluate the biphasic dissolution system as discriminatory tool to differentiate between manufacture process and different excipient use for Class IV drug. Furosemide was prepared by two different methods: direct compression and wet granulation. Different excipients (acid and base) were used for each method. Furthermore, two commercially available products (Lasix® and generic product FA) were used for comparison with the prepared formulation. All formulations were evaluated for physical properties like hardness, friability and disintegration. Monophasic and biphasic dissolution tests were carried out for all formulas. All physical properties of the prepared tablets were within acceptable values. The dissolution rates of all three types of formulas (brand, generic, and prepared formulation) were identical under monophasic conditions. The similarity factor was more than 50 and difference factor less than 15. On the other hand, the biphasic dissolution profiles (aqueous phase, organic phase and overall dissolution media) showed significant differences between all prepared formulations and the brand product. Moreover, the two phase system still had the ability to show the similarity between brand and generic product. Furthermore, the direct compression method showed lower release than wet granulation method. Similarly, the acid excipients showed higher release than the basic one. As a conclusion, the biphasic dissolution system showed an excellent discriminatory power. Moreover, this approach was superior over conventional dissolution system regarding identifying variations in production processes and excipients content.
Received: 8/ 2/ 2023
Accepted: 19/ 4/2023
How to Cite
Publication Dates
References
Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical research. 1995;12(3):413-20.
Da Silva FLO, Marques MBDF, Kato KC, Carneiro G. Nanonization techniques to overcome poor water-solubility with drugs. Expert opinion on drug discovery. 2020;15(7):853-64.
Siewert M, Dressman J, Brown CK, Shah VP, Aiache J-M, Aoyagi N, et al. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. Aaps Pharmscitech. 2003;4(1):43-52.
Shah VP, Tymes NW, Skelly JP. In vitro release profiles of clonidine transdermal therapeutic systems and scopolamine transdermal patches. Pharmaceutical research. 1989;6(4):346-51.
Thiry J, Broze G, Pestieau A, Tatton AS, Baumans F, Damblon C, et al. Investigation of a suitable in vitro dissolution test for itraconazole-based solid dispersions. European Journal of Pharmaceutical Sciences. 2016;85:94-105.
Shi Y, Gao P, Gong Y, Ping H. Application of a biphasic test for characterization of in vitro drug release of immediate release formulations of celecoxib and its relevance to in vivo absorption. Molecular pharmaceutics. 2010;7(5):1458-65.
Heigoldt U, Sommer F, Daniels R, Wagner K. Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik eV. 2010;76:105-11.
Kinget R, Greef Hd. Absorption characteristics of novel 8-MOP semi-solid-lipid-matrix formulations: In vitro-in vivo correlation. International Journal of Pharmaceutics. 1994;110:65-73.
Kostewicz ES, Abrahamsson B, Brewster M, Brouwers J, Butler J, Carlert S, et al. In vitro models for the prediction of in vivo performance of oral dosage forms. European Journal of Pharmaceutical Sciences. 2014;57:342-66.
Moosavi SM, Ghassabian S. Linearity of calibration curves for analytical methods: A review of criteria for assessment of method reliability: IntechOpen Limited London, UK; 2018.
Bhowmik D, Jayakar B, Kumar KS. Design and characterisation of fast dissolving tablet of telmisartan. Int J Pharm Recent Res. 2009;1(1):31-40.
Abbas A, Ibrahim W, Sakran W, Badawi A. Evaluation and Characterization of Sildenafil 50 mg Orodispersible Tablets Using Sublimation Technique. Journal of Advanced Pharmacy Research. 2018;2(4):292-311.
Jaman M, Chowdhury A, Rana A, Masum S, Ferdous T, Rashid M, et al. In vitro evaluation of Ciprofloxacin Hydrochloride. Bangladesh Journal of Scientific and Industrial Research. 2015;50(4):251-6.
Deng J. Development of discriminative and predictive dissolution tests for immediate release oral dosage forms of poorly soluble drugs 2017.
Hamed R, Alnadi SH, Awadallah A. The effect of enzymes and sodium lauryl sulfate on the surface tension of dissolution media: toward understanding the solubility and dissolution of carvedilol. AAPS PharmSciTech. 2020;21(5):1-11.
Amaral Silva D, Al-Gousous J, Davies NM, Bou Chacra N, Webster GK, Lipka E, et al. Biphasic dissolution as an exploratory method during early drug product development. Pharmaceutics. 2020;12(5):420.
Deng J, Staufenbiel S, Hao S, Wang B, Dashevskiy A, Bodmeier R. Development of a discriminative biphasic in vitro dissolution test and correlation with in vivo pharmacokinetic studies for differently formulated racecadotril granules. Journal of Controlled Release. 2017;255:202-9.
Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, et al. An introduction to the approaches used by DDSolver. Electronic supplementary material (doi: 101208/s12248-010-9185-1). 2010.
Sahib MN, Abdulameer SA, Darwis Y, Peh KK, Tan YTF. Solubilization of beclomethasone dipropionate in sterically stabilized phospholipid nanomicelles (SSMs): physicochemical and in vitro evaluations. Drug design, development and therapy. 2012;6:29.
Sahib MN, Darwis Y, Peh KK, Abdulameer SA, Tan YTF. Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations. International journal of nanomedicine. 2011;6:2351.
Sahib MN, Darwis Y, Peh KK, Abdulameer SA, Fung Tan YT. Incorporation of Beclomethasone Dipropionate into Polyethylene Glycol‐Diacyl Lipid Micelles as a Pulmonary Delivery System. Drug Development Research. 2012;73(2):90-105.
Tan YT, Abdulameer SA, Peh KK, Darwis Y, Sahib MN. Polyethylene glycol-phosphatidylethanolamine conjugate as a pulmonary nanocarrier for poorly soluble drug. Latin American Journal of Pharmacy. 2012;31.
Yuksel N, Kanık AE, Baykara T. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and-independent methods. International journal of pharmaceutics. 2000;209(1-2):57-67.
Chow S-C, Fanny YK. Statistical comparison between dissolution profiles of drug products. Journal of Biopharmaceutical Statistics. 1997;7(2):241-58.
Limnell T, Santos HA, Mäkilä E, Heikkilä T, Salonen J, Murzin DY, et al. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods. Journal of pharmaceutical sciences. 2011;100(8):3294-306.
Dular Vovko A, Hodžić B, Brec T, Hudovornik G, Vrečer F. Influence of Formulation Factors, Process Parameters, and Selected Quality Attributes on Carvedilol Release from Roller-Compacted Hypromellose-Based Matrix Tablets. Pharmaceutics. 2022;14(4):876.
Ferrero C, Munoz N, Velasco M, Muñoz-Ruiz A, Jiménez-Castellanos R. Disintegrating efficiency of croscarmellose sodium in a direct compression formulation. International journal of pharmaceutics. 1997;147(1):11-21.
Kanojia N, Kaur L, Nagpal M, Bala R. Modified excipients in novel drug delivery: Need of the day. 2014.
Gorain B, Choudhury H, Pandey M, Madheswaran T, Kesharwani P, Tekade RK. Drug–excipient interaction and incompatibilities. Dosage form design parameters: Elsevier; 2018. p. 363-402.
Parikh DM. Handbook of pharmaceutical granulation technology. Drugs and the pharmaceutical sciences. 2005;81.
Baradari H, Damia C, Dutreih-Colas M, Laborde E, Pécout N, Champion E, et al. Calcium phosphate porous pellets as drug delivery systems: Effect of drug carrier composition on drug loading and in vitro release. Journal of the European Ceramic Society. 2012;32(11):2679-90.
Choi A, Ben-Nissan B, Matinlinna J, Conway R. Current perspectives: calcium phosphate nanocoatings and nanocomposite coatings in dentistry. Journal of Dental Research. 2013;92(10):853-9.
Patel RR. Development of nanocarrier systems for oral delivery of poorly premeable hydrophilic drug-cromolyn sodium 2016.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Iraqi Journal of Pharmaceutical Sciences( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)
This work is licensed under a Creative Commons Attribution 4.0 International License.
